Clinical Trial

A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wrinkles, Fine Lines, and Dark Spots.

Completed
View on ClinicalTrials.gov →
Summary
A Randomized, Double-Blind, Three-Arm, Prospective, Single-Center Clinical Study to Evaluate the Safety, Efficacy, and Tolerability of Pinorox® in Subjects with Facial Signs of Aging
Protocol Amendment History 2 changes
critical Trial completed 2026-08-06
notable Primary completion moved earlier: 2026-02-17 -> 2025-10-17 2026-08-06
Trial Details
NCT Number NCT07111156
Lead Sponsor NovoBliss Research Pvt Ltd
Collaborators: Ambe Phytoextracts Pvt. Ltd
Conditions Fine Lines, Wrinkles, Facial Sign of Aging
Enrollment 81 participants
Start Date 2025-10-16
Primary Completion 2025-10-17 (estimated)
Study Completion 2026-02-17 (estimated)
Updated on ClinicalTrials.gov 2026-08-05